Rate My Professor Myfanwy Graham

Graham was honored with the Fulbright Postgraduate Scholarship in 2021, becoming the first Australian in her field to receive this prestigious award. She conducted her Fulbright research at the University of Southern California in Los Angeles, partnering with Professor Rosalie Pacula on a binational study examining medicinal cannabis policies, patient outcomes, clinical practices, and regulatory differences between Australia and the United States. The project aimed to forge global research collaborations, translate findings into clinical settings, and drive policy improvements for better patient care. Her contributions extend to the NSW Cannabis Medicines Advisory Service, where she co-authored key reports including preliminary survey results on enquirer perceptions and patient outcomes (2021) and a retrospective enquiry analysis (2024). Notable peer-reviewed publications include 'Cannabidiol drug interaction considerations for prescribers and patients' (2023), 'Opioid-sparing effect of cannabinoids for analgesia' in Neuropsychopharmacology (2022), 'Over the counter low-dose cannabidiol: A viewpoint from the ACRE group' in Journal of Psychopharmacology (2021), 'From growers to patients: Multi-stakeholder views on the use of, and attitudes toward, medical cannabis in New Zealand' (2022), 'Understanding medical cannabis use internationally: Why prescribers need more support' in Addiction (2025), and 'The safety and efficacy of cannabinoids for the treatment of mental health conditions: a systematic review' (2025). Graham's work has advanced evidence-based practices in cannabinoid therapeutics and supported prescribers through guidance resources.